Related Experiment Videos
Clinical considerations in the use of risperidone
1University of Toronto, Schizophrenia Research Program, Clarke Institute of Psychiatry, Ontario.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|September 1, 1993
Summary
Risperidone is an effective antipsychotic for schizophrenia, offering a better side-effect profile than older drugs. Clinicians can consider switching to risperidone for improved symptom control and reduced adverse effects.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- Risperidone demonstrates efficacy in treating positive and negative symptoms of schizophrenia.
- Its side-effect profile is comparatively favorable to standard neuroleptics.
- Potential for use as a first-line treatment for schizophrenia exists.
Purpose of the Study:
- To discuss clinical considerations for switching patients to risperidone.
- To provide practical guidelines for risperidone therapy, including dosing and treatment course.
- To highlight risperidone as an alternative for patients with inadequate symptom control or problematic side effects from other neuroleptics.
Main Methods:
- Review of existing clinical studies on risperidone.
- Analysis of side-effect profiles compared to standard neuroleptics.
- Development of practical guidelines for therapeutic transition and management.
Main Results:
- Risperidone is effective for both positive and negative schizophrenic symptoms.
- Superiority in side-effect profile compared to traditional neuroleptics, notably reduced extrapyramidal symptoms and tardive dyskinesia.
- Clinical utility as a first-line agent or switch therapy for schizophrenia.
Conclusions:
- Risperidone is a valuable therapeutic option in schizophrenia management.
- Consideration for switching to risperidone is warranted for patients experiencing poor efficacy or intolerable side effects.
- Practical guidelines facilitate safe and effective implementation of risperidone therapy.